• Print

Confirmed Sponsors

Platin Sponors

   


  Today, Fresenius Medical Care is the world's largest, integrated provider of products and services for individuals with chronic kidney failure, a condition that affects more than 2.1 million individuals worldwide. Through its network of 3,123 dialysis clinics in North America, Europe, Latin America, Asia-Pacific and Africa, Fresenius Medical Care provides dialysis treatment to 256,456 patients around the globe. Fresenius Medical Care is also the world's largest provider of dialysis products, such as hemodialysis machines, dialyzers and related disposable products. 



Gold Sponsors

  HeartWare, Inc. is a medical device company and leading innovator of miniaturized circulatory support technologies to treat patients suffering from advanced heart failure. Through a cadence of progressively smaller devices, implanted with progressively less invasive surgery, HeartWare is working toward treating an increasing proportion of heart failure patients and accessing patients at an earlier stage of their disease progression. HeartWare's lead product, the HeartWare® Ventricular Assist System, features the HVAD® pump, a miniaturized implantable centrifugal pump capable of producing up to 10 liters per minute of blood flow. The pump is designed to be implanted above the diaphragm, directly adjacent to the heart, thereby avoiding the abdominal surgery generally required to implant competing devices.
In 2009, HeartWare received CE marking for the System and it is now commercially available in Europe. In March 2011, the Therapeutic Goods Administration (TGA) in Australia approved the HeartWare® Ventricular Assist System for listing on the Australian Register of Therapeutic Goods (ARTG). The device is currently the subject of United States clinical trials for two indications: Bridge-to-Transplant and Destination Therapy. To date, more than 1,800 advanced heart failure patients have received the HVAD Pump in more than 22 countries worldwide. 


  Tokyo-based Terumo Corporation is one of the world’s leading medical device manufacturers with $4 billion in sales and operations in more than 160 nations. Founded in 1921, the company develops, manufactures, and distributes world-class medical devices including products for use in cardiothoracic surgery, interventional procedures, and transfusion medicine; the company also manufactures a broad array of syringe and hypodermic needle products for hospital and physician office use.



   


  With 20 years of experiences around the world, Infomed has comforted its leadership as a provider of extracorporeal blood purification devices offering complete solutions with many advanced medical treatments such as: Continuous hemofiltration and hemodiafiltration, plasma exchange, double filtration plasmapheresis (DFPP), cascade filtration, blood or plasma perfusion and CPFA (Coupled Plasma Filtration Adsorption). Infomed provides a complete range of machines and all associated disposables such as pre-assembled kits, filters and adsorption cartridges.  



Silver Sponors

  Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives.
Our technologies are categorized into our four business units - heart valve therapy, critical care, cardiac surgery systems and vascular – each with a rich history and unique patient focus. We also lead the development of new investigative technologies designed for the non-surgical replacement of heart valves and minimal invasive cardiovascular techniques. We believe that these challenging new procedures hold great promise for patients considered high-risk for conventional valve replacement as this technology allows clinicians to deliver valves via a catheter, eliminating the need for traditional open-heart surgery. 


 

As a trusted partner for hospitals and clinicians since 1838, Maquet is a global leader in medical systems that advance surgical interventions, cardiovascular procedures and critical care. Maquet develops and designs innovative products and therapeutic applications for the operating room, hybrid OR/cathlab, intensive care unit, and patient transport within acute care hospitals, improving outcomes and quality of life for patients.

MAQUET – The Gold Standard. For more information please visit www.maquet.com and www.getingegroup.com. 


   


  The Nikkiso group has been providing extracorporeal technologies and products in order to meet demands of our customer and patients, the society and the times we live in for more than half a century. We are recognized as precision machinery company in the field of blood purification and hemodialysis. Beside our huge expertise in the development and production of technology and medical equipment our R&D team recently developed a new adsorptive device for the treatment of Ulcerative Colitis patients.

Based in Hanover/Germany the Nikkiso Europe is responsible for the development, production and sales of Nikkiso products in the EMEA region.


  Miltenyi Biotec, founded in 1989, is a premier provider of advanced products and services in the fields of stem cells, immune and cellular therapies as well as tissue regeneration. With more than 1200 employees worldwide, we develop, manufacture and commercialize state-of the-art technologies for research and clinical applications. Our products and services cover all areas of cell-based research and clinical development, from sample preparation, cell separation, cell culture, flow cytometric and molecular analysis, to clinical therapeutic applications and contract GMP manufacturing.


  CytoSorbents is a medtech company using blood purification to modulate the immune system and fight multi-organ failure in life-threatening illnesses. Its technology is based on biocompatible, highly porous polymer beads that can remove toxic substances from blood by pore capture and adsorption. In 2011, CytoSorb® achieved CE approval as an extracorporeal cytokine filter to be used in patients with elevated cytokines. CytoSorb® modulates the immune system by reducing "cytokine storm" that could otherwise lead to deadly inflammation, multiple organ failure, immune dysfunction, and often death in illnesses such as sepsis, trauma, burn injury, ARDS, pancreatitis amd other systemic inflammatory syndromes. CytoSorb filters are commercially available in Germany, Austria, Switzerland and selected European countries. 


   


  Since 2006 HepaNet is responsible in the field of liver dialysis business in Germany, representing the Albumin-Dialysis. Besides the classical sale of consumables HepaNet draws from our individual therapy service in case of emergency. We also offer since 2011 pocket ultrasonic devices from GE Healthcare. 


  The SynCardia temporary Total Artificial Heart (TAH-t) is the world’s only FDA, Health Canada and CE approved Total Artificial Heart. The TAH-t is currently approved as a bridge to transplant for patients dying from end-stage biventricular failure. The 13.5 lb Freedom™ portable driver has received CE approval in Europe and is undergoing an IDE clinical study in the U.S. The Freedom driver is designed to provide mobility for stable TAH-t patients both inside and outside the hospital. Visit our booth for updates on the clinical study, the 50cc TAH-t and destination therapy. 


 

Kaneka Pharma Europe N.V is the major enterprise in developing and commercializing medical devices as vascular intervention and therapeutic apharesis products, functional food ingredients as Co-Q10 and pharmaceutical ingredients for mainly statins and ACE-i for the healthcare sector.

This combination and our long experience in those fields make it possible, that Kaneka is the expert in successfully supporting the CVD management interventions.